These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30361925)

  • 41. Lifetime Prevalence and Correlates of Schizophrenia-Spectrum, Affective, and Other Non-affective Psychotic Disorders in the Chinese Adult Population.
    Chang WC; Wong CSM; Chen EYH; Lam LCW; Chan WC; Ng RMK; Hung SF; Cheung EFC; Sham PC; Chiu HFK; Lam M; Lee EHM; Chiang TP; Chan LK; Lau GKW; Lee ATC; Leung GTY; Leung JSY; Lau JTF; van Os J; Lewis G; Bebbington P
    Schizophr Bull; 2017 Oct; 43(6):1280-1290. PubMed ID: 28586480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early detection and intervention of psychosis. A review.
    Salokangas RK; McGlashan TH
    Nord J Psychiatry; 2008; 62(2):92-105. PubMed ID: 18569772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
    Leadbeater BJ; Ames ME; Linden-Carmichael AN
    Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First-psychotic episode in childhood and adolescence.
    Radmanović MB
    Psychiatr Danub; 2012 Oct; 24 Suppl 3():S388-91. PubMed ID: 23114822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EPA guidance on the early detection of clinical high risk states of psychoses.
    Schultze-Lutter F; Michel C; Schmidt SJ; Schimmelmann BG; Maric NP; Salokangas RK; Riecher-Rössler A; van der Gaag M; Nordentoft M; Raballo A; Meneghelli A; Marshall M; Morrison A; Ruhrmann S; Klosterkötter J
    Eur Psychiatry; 2015 Mar; 30(3):405-16. PubMed ID: 25735810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lifetime psychopathological dimensions, cognitive impairment and functional outcome in psychosis.
    Sánchez-Torres AM; Elosúa MR; Lorente-Omeñaca R; Moreno-Izco L; Peralta V; Cuesta MJ
    Schizophr Res; 2017 Jan; 179():30-35. PubMed ID: 27733302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Course of clinical high-risk states for psychosis beyond conversion.
    Michel C; Ruhrmann S; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):39-48. PubMed ID: 28054132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.
    Sheffield JM; Karcher NR; Barch DM
    Neuropsychol Rev; 2018 Dec; 28(4):509-533. PubMed ID: 30343458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of symptoms and insight in mediating cognition and functioning in first episode psychosis.
    Lee EHM; Hui CLM; Chan KPK; Chan PY; Law EYL; Chong CSY; Chang WC; Chan SKW; Lee WK; Lo AWF; Pang EPF; Cheung EFC; Yiu MGC; Chung DWS; Ng RMK; Yeung WS; Lo WTL; Chen EYH
    Schizophr Res; 2019 Apr; 206():251-256. PubMed ID: 30449592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?
    Armando M; Schneider M; Pontillo M; Vicari S; Debbané M; Schultze-Lutter F; Eliez S
    PLoS One; 2017; 12(4):e0174797. PubMed ID: 28406913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the 'Jumping to conclusions' bias in different subgroups of the at-risk mental state: from cognitive basic symptoms to UHR criteria.
    Rausch F; Eisenacher S; Elkin H; Englisch S; Kayser S; Striepens N; Lautenschlager M; Heinz A; Gudlowski Y; Janssen B; Gaebel W; Michel TM; Schneider F; Lambert M; Naber D; Juckel G; Krueger-Oezguerdal S; Wobrock T; Hasan A; Riedel M; Moritz S; Müller H; Klosterkötter J; Bechdolf A; Zink M; Wagner M
    Psychol Med; 2016 Jul; 46(10):2071-81. PubMed ID: 27094404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of demographic characteristics on attenuated positive psychotic symptoms in a young, help-seeking, at-risk population.
    Theodoridou A; Hengartner MP; Heekeren K; Dvorsky D; Schultze-Lutter F; Gerstenberg M; Walitza S; Rössler W
    Early Interv Psychiatry; 2019 Feb; 13(1):53-56. PubMed ID: 28417595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms.
    Addington J; Liu L; Perkins DO; Carrion RE; Keefe RS; Woods SW
    Schizophr Bull; 2017 Jan; 43(1):57-63. PubMed ID: 27798225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Precursors of cognitive impairments in psychotic disorders: a population-based study.
    Müller M; Vetter S; Weiser M; Frey F; Ajdacic-Gross V; Stieglitz RD; Rössler W
    Psychiatry Res; 2013 Nov; 210(1):329-37. PubMed ID: 23876280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [First-episodes psychosis: clinical and epidemiological news].
    Tournier M
    Encephale; 2013 Sep; 39 Suppl 2():S74-8. PubMed ID: 24084425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis.
    Zimmermann R; Gschwandtner U; Wilhelm FH; Pflueger MO; Riecher-Rössler A; Fuhr P
    Schizophr Res; 2010 Nov; 123(2-3):208-16. PubMed ID: 20850950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [What support of young presenting a first psychotic episode, when schooling is being challenged?].
    Vacheron MN; Veyrat-Masson H; Wehbe E
    Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loneliness in psychotic disorders and its association with cognitive function and symptom profile.
    Badcock JC; Shah S; Mackinnon A; Stain HJ; Galletly C; Jablensky A; Morgan VA
    Schizophr Res; 2015 Dec; 169(1-3):268-273. PubMed ID: 26527247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.